Icon

FEMRING (nda021367)- (EQ 0.05MG BASE/24HR,EQ 0.1MG BASE/24HR)

ESTRADIOL ACETATE MILLICENT
EQ 0.05MG BASE/24HR,EQ 0.1MG BASE/24HR
No No
2015-Dec-19 Expired
None None
None No
Femring therapy is indicated in the: 1. Treatment of moderate to severe vasomotor symptoms associated with the menopause. 2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 0.05MG BASE/24HR ** ** Up - -
EQ 0.1MG BASE/24HR ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.